Related Experiment Videos

Second/third/fourth line therapy with tyrosine kinase inhibitors in NSCLC

Nico Van Zandwijk1, Paul Baas

  • 1Department of Thoracic Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Abstract

No abstract available in PubMed .

Related Concept Videos